HT Vet LTD, established in 2021 as a subsidiary of HT Bioimaging (founded in 2015), is at the forefront of revolutionizing cancer diagnostics in veterinary medicine. The company’s flagship product, HT Vista, is the first AI-driven, non-invasive tool that allows veterinary professionals to confidently rule out cancer in dermal and subcutaneous masses in dogs.

 

With a mission to save pets’ lives through early diagnosis, HT Vista leverages the company's proprietary Heat Diffusion Imaging (HDI) technology and cloud-based analysis to deliver quick, on-the-spot results within a vet’s practice. Backed by a diverse team of experts in veterinary medicine, algorithms, engineering, and design, HT Vet brings together extensive knowledge to change the way cancer is diagnosed in pets worldwide.